Independent CE Satellite Symposium: Oncolytic Therapy for Melanoma: Hands-On Training
9:00 AM - 10:30 AM ET
Independent CE Satellite Symposium: Oncolytic Therapy for Melanoma: Hands-On Training
Separate Registration Required
CE/CME: 1.50 credits/hours
11:00 AM - 12:30 PM ET
Independent CE Satellite Symposium: Oncolytic Therapy for Melanoma: Hands-On Training (Repeat of 9:00 am Session)
11:00 AM - 12:30 PM ET
Independent CE Satellite Symposium (Repeat of 9:00 am Session): Oncolytic Therapy for Melanoma: Hands-On Training
Separate Registration Required
CE/CME: 1.50 credits/hours
11:00 AM - 3:00 PM ET
Braindate
11:00 AM - 3:00 PM ET
Braindate
1:00 PM - 3:00 PM ET
Pre-Conference Session Advances in Cancer Immunotherapy (ACI): Managing Multi-Organ Toxicities Associated With Cell Therapies and Immune Checkpoint Inhibitors Collaboration between Society for Immunotherapy in Cancer (SITC) & APSHO
1:00 PM - 3:00 PM ET
Pre-Conference Session Advances in Cancer Immunotherapy (ACI): Managing Multi-Organ Toxicities Associated With Cell Therapies and Immune Checkpoint Inhibitors Collaboration between Society for Immunotherapy in Cancer (SITC) & APSHO
Independent CE Satellite Symposium: Non-Small Cell Lung Cancer: Updates on Molecular Diagnostics, Targeted Treatment, and Adverse Event Management for Optimized Patient Outcomes
2:00 PM - 3:00 PM ET
Independent CE Satellite Symposium: Non-Small Cell Lung Cancer: Updates on Molecular Diagnostics, Targeted Treatment, and Adverse Event Management for Optimized Patient Outcomes
CE/CME: 0.75
2:45 PM - 3:30 PM ET
Refreshment Break
2:45 PM - 3:30 PM ET
Refreshment Break
3:00 PM - 4:00 PM ET
Non-CE Satellite Symposium: Evolving Strategies for Locally Advanced or Metastatic EGFR-mutated NSCLC and HR+/HER2– (IHC 0, IHC 1+, IHC 2+/ISH–) mBC AstraZeneca
3:00 PM - 4:00 PM ET
Non-CE Satellite Symposium: Evolving Strategies for Locally Advanced or Metastatic EGFR-mutated NSCLC and HR+/HER2– (IHC 0, IHC 1+, IHC 2+/ISH–) mBC AstraZeneca
3:00 PM - 4:00 PM ET
Non-CE Satellite Symposium: Partnering to Deliver Continuity of Care with Elrexfio (A BCMA-Directed Bispecific Immunotherapy for Certain Adult Patients With Relapsed or Refractory Multiple Myeloma). Pfizer, Inc.
3:00 PM - 4:00 PM ET
Non-CE Satellite Symposium: Partnering to Deliver Continuity of Care with Elrexfio (A BCMA-Directed Bispecific Immunotherapy for Certain Adult Patients With Relapsed or Refractory Multiple Myeloma). Pfizer, Inc.
3:00 PM - 4:00 PM ET
Non-CE Satellite Symposium: Review of Evidence-Based Data for an Antibody-Drug Conjugate in Combination with a PD-1 Inhibitor for 1L LA/MUC Astellas Pharma & Pfizer Oncology
3:00 PM - 4:00 PM ET
Non-CE Satellite Symposium: Review of Evidence-Based Data for an Antibody-Drug Conjugate in Combination with a PD-1 Inhibitor for 1L LA/MUC Astellas Pharma & Pfizer Oncology
4:00 PM - 6:00 PM ET
Pre-Conference Seminar: Addressing Psychological Burdens Throughout the Continuum of Care
4:00 PM - 6:00 PM ET
Pre-Conference Seminar: Addressing Psychological Burdens Throughout the Continuum of Care
